期刊文献+

基于能谱CT参数与临床病理因素建立高海拔地区非小细胞肺癌患者的淋巴结转移预测模型 被引量:4

Establishment of a prediction model of lymph node metastasis in patients with non-small cell lung cancer at high altitude areas based on energy spectrum CT parameters and clinicopathological factors
下载PDF
导出
摘要 目的探讨高海拔地区非小细胞肺癌(NSCLC)患者的淋巴结转移的能谱CT参数、临床病理因素、影响因素及其预测模型的应用效能。方法选取青海省人民医院2020年1月-2021年7月收治的84例NSCLC患者作为研究对象,其中50例患者进行能谱CT检测并收集临床资料。依据淋巴结转移病理检查结果将50例患者分为转移组、未转移组,采用单因素分析2组患者的临床病理因素、能谱CT参数差异,采用多因素回归分析NSCLC患者发生淋巴结转移的影响因素并建立预测模型。应用预测模型分析其他34例NSCLC患者的淋巴结转移情况,以临床检测结果为金标准,评估预测模型的应用价值。结果①50例患者的淋巴结转移发生率为30.00%。转移组患者的术前癌胚抗原(CEA)、中央型隆突位置比率、淋巴结直径高于未转移组,差异有统计学意义(P<0.05)。②转移组患者的淋巴结能谱曲线斜率(λHu)、标准化碘密度值(NIC)、淋巴结与原发病灶的λHu比值均低于未转移组,差异有统计学意义(P<0.05)。③NSCLC患者发生淋巴结转移的危险因素为淋巴结与原发病灶的λHu比值、术前CEA≥5 ng/mL、淋巴结直径≥3 cm。④NSCLC患者淋巴结转移的预测模型诊断34例NSCLC患者的准确度、特异度、敏感度均在80.00%以上。结论NSCLC患者淋巴结转移中可应用能谱CT参数以及临床病理因素中的相关危险因素建立预测模型进行准确预测,该模型可作为预测淋巴结转移的首选工具。 Objective To explore the energy spectrum CT parameters,clinicopathological factors,influencing factors and the application efficiency of the prediction model of lymph node metastasis in patients with non-small cell lung cancer(NSCLC)at high altitude area.Methods A total of 84 NSCLC patients from January 2020 to July 2021 in Qinghai Provincial People′s Hospital were selected as research objects,of whom 50 patients were conducted with energy spectrum CT detection and their clinical materials were collected.According to the pathological examination results of lymph node metastasis,50 patients were divided into metastasis group and non-metastasis group,the differences of clinicopathological factors and energy spectrum CT parameters between the two groups were analyzed by univariate analysis,the influencing factors of lymph node metastasis in NSCLC patients were analyzed by multivariate regression analysis,and a prediction model was established.The prediction model was used to analyze the lymph node metastasis of the other 34 NSCLC patients,and the clinical test results were used as the gold standard to evaluate the application value of the prediction model.Results①The incidence of lymph node metastasis in 50 patients was 30.00%.The preoperative carcinoembryonic ratio of central carina position and lymph node diameter in the metastasis group were significantly higher than those in the non-metastasis group(P<0.05).②Slope of energy spectrum curve of lymph nodes(λHu),normalized iodine concentration(NIC)andλHu ratio of lymph nodes to primary lesions in the metastasis group were significantly lower than those in the non-metastasis group(P<0.05).③The risk factors of lymph node metastasis in NSCLC patients were theλHu ratio of lymph nodes to primary lesions,preoperative CEA≥5 ng/mL and lymph node diameter≥3 cm.④The accuracy,specificity and sensitivity of the prediction model for lymph node metastasis in 34 patients with NSCLC were all above 80.00%.Conclusion In the NSCLC patients with lymph node metastasis,energy spectrum CT parameters and related risk factors in clinicopathological factors can be used to establish a prediction model for accurate prediction,and this model can be used as the preferred tool to predict lymph node metastasis.
作者 胡志鹏 冶治 张庆欣 HU Zhipeng;YE Zhi;ZHANG Qingxin(Department of Thoracic Surgery,Qinghai Provincial People′s Hospital,Xining,Qinghai,810000)
出处 《实用临床医药杂志》 CAS 2022年第18期6-10,共5页 Journal of Clinical Medicine in Practice
基金 青海省科技计划项目(2019-ZJ-931)。
关键词 能谱CT参数 临床病理因素 高海拔地区 非小细胞肺癌 淋巴结转移 预测模型 医工结合 energy spectrum CT parameters clinicopathological factors high altitude areas non-small cell lung cancer lymph node metastasis prediction model combination of medicine and engineering
  • 相关文献

参考文献7

二级参考文献57

  • 1陆舜,虞永峰,吴春晓,李子明,周允中,郑莹,赵晓菁,廖美琳.淋巴结转移数和病灶大小在可手术非小细胞肺癌预后中的意义[J].肿瘤,2007,27(12):973-976. 被引量:8
  • 2Torre LA,Bray F,Siegel RL,et al. Global cancer statis- tics, 2012[J]. CA Cancer J Clin, 2015,65(2) : 87-108.
  • 3Inoue M,Sawabata N,Okumura M. Surgical intervention for small-cell lung cancer:what is the surgical role?[J]. Gen Thorac Cardiovasc Surg, 2012,60(7) : 401-405.
  • 4Loehe F,Kobinger S,Hatz RA,et al. Value of systematic mediastinal lymph node dissection during pulmonary metastasectomy[J]. Ann Thorac Surg, 2001,72(1) : 225-229.
  • 5Eisenhauer EA,Therasse P,Bogaerts J,et al. New re- sponse evaluation criteria in solid tumours :revised RE- CIST guideline (version 1.1)[J]. Eur J Cancer,2009,45(2): 228-247.
  • 6Lv P, Lin XZ, Li J,et al. Differentiation of small hepatic hemangioma from small hepatocellular carcinoma:recently introduced spectral CT method[J]. Radiology, 2011,259 (3) : 720-729.
  • 7Fraioli F, Anzidei M, Zaccagna F, et al. Whole-tumor per- fusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemothera- py:initial experience[J]. Radiology, 2011,259(2) : 574-582.
  • 8李军,李玉,玉寒冰,刘凡英,王洲.中心型肺癌侵袭深度与淋巴结转移的关系[J].中国肺癌杂志,2009,12(6):466-466. 被引量:2
  • 9边聪,刘辉,陈刚,周冬梅,沈波.CN_0舌鳞癌颈部淋巴结隐匿性微转移与预后的研究[J].临床口腔医学杂志,2009,25(10):587-589. 被引量:1
  • 10林晓珠,李卫侠,朱延波,董海鹏,吕培杰,缪飞,李剑颖,沈云,陈克敏.宝石能谱CT在肿瘤诊断中的初步应用[J].诊断学理论与实践,2010,9(2):155-160. 被引量:127

共引文献85

同被引文献60

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部